SEC 13F Intelligence

Commodore Capital LP / CYTK

Commodore Capital LP’s Cytokinetics Inc Position

Does Commodore Capital LP own Cytokinetics Inc (CYTK)? Not currently — the last reported position was 893.6K shares worth $43M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$43M
Q3 2022
Shares
893.6K
% of Portfolio
+6.96%
Quarters Held
6
position exited

Position History CYTK

Reported value by quarter
Q2 ’21: $14MQ2 ’21Q3 ’21: $28MQ3 ’21Q4 ’21: $32MQ4 ’21Q1 ’22: $31MQ1 ’22Q2 ’22: $35MQ2 ’22Q3 ’22: $43MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022893.6K$43M+6.96%
Q2 2022893.6K$35M+7.42%
Q1 2022854.7K$31M+7.03%
Q4 2021704.5K$32M+7.44%
Q3 2021796.6K$28M+7.51%
Q2 2021704.3K$14M+4.80%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commodore Capital LP’s full portfolio or all institutional holders of CYTK.